Metropolis Healthcare unveils key findings from Molecular Genomics Study

The study analysed data from over 3,200 individuals diagnosed with lung cancer, focusing on genetic alterations in key genes such as Epidermal Growth Factor Receptor (EGFR), Anaplastic Lymphoma Kinase (ALK), and c-ros oncogene 1 (ROS1)
The post Metropolis Healthcare unveils key findings from Molecular Genomics Study appeared first on Express Healthcare.